Stock Research: CVS Group

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

CVS Group

AIM:CVSG GB00B2863827
29
  • Value
    42
  • Growth
    23
  • Safety
    Safety
    31
  • Combined
    10
  • Sentiment
    67
  • 360° View
    360° View
    29
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

CVS Group plc provides veterinary services; it operates in Veterinary Practices, Laboratories, and Online Retail Business, with brands like Animed Direct, MiPet, and EqueVet-Pro. It has operations in the United Kingdom and Australia. In the last fiscal year, the company had 8822 employees, a market cap of $1173 millions, profits of $351 millions, and revenue of $818 millions.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 29 (better than 29% compared with alternatives), overall professional sentiment and financial characteristics for the stock CVS Group are below the industry average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for CVS Group. The consolidated Sentiment Rank has a good rank of 67, which means that professional investors are more optimistic about the stock than for 67% of alternative investment opportunities. But all other ranks are below average. The consolidated Value Rank has a rank of 31, which means that the share price of CVS Group is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. The consolidated Growth Rank also has a low rank of 23, meaning that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. This means that growth is lower than for 23% of competitors in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 42 which means that the company has a riskier financing structure than 58% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
31 52 28 39
Growth
23 10 5 39
Safety
Safety
42 51 58 37
Sentiment
67 20 46 65
360° View
360° View
29 9 16 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
73 63 81 65
Opinions Change
50 31 10 50
Pro Holdings
n/a 18 48 15
Market Pulse
44 35 67 80
Sentiment
67 20 46 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
31 52 28 39
Growth
23 10 5 39
Safety Safety
42 51 58 37
Combined
10 26 12 22
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
60 78 57 52
Price vs. Earnings (P/E)
43 57 51 58
Price vs. Book (P/B)
21 41 12 28
Dividend Yield
41 47 30 35
Value
31 52 28 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
61 25 43 34
Profit Growth
30 20 31 23
Capital Growth
4 75 9 36
Stock Returns
57 8 31 87
Growth
23 10 5 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
29 31 50 36
Refinancing
30 34 35 25
Liquidity
52 54 50 34
Safety Safety
42 51 58 37

Similar Stocks

Discover high‑ranked alternatives to CVS Group and broaden your portfolio horizons.

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Smith & Nephew

LSE:SN.
Country: United Kingdom
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Vodafone

LSE:VOD
Country: United Kingdom
Industry: Wireless Telecommunication
Size: X-Large
Full Stock Analysis

Fresenius

XTRA:FRE
Country: Germany
Industry: Health Care Services
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.